Does THIOTEPA Cause Malignant neoplasm progression? 52 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 52 reports of Malignant neoplasm progression have been filed in association with THIOTEPA (Thiotepa). This represents 0.8% of all adverse event reports for THIOTEPA.
52
Reports of Malignant neoplasm progression with THIOTEPA
0.8%
of all THIOTEPA reports
30
Deaths
11
Hospitalizations
How Dangerous Is Malignant neoplasm progression From THIOTEPA?
Of the 52 reports, 30 (57.7%) resulted in death, 11 (21.2%) required hospitalization, and 2 (3.8%) were considered life-threatening.
Is Malignant neoplasm progression Listed in the Official Label?
Yes, Malignant neoplasm progression is listed as a known adverse reaction in the official FDA drug label for THIOTEPA.
What Other Side Effects Does THIOTEPA Cause?
Off label use (762)
Febrile neutropenia (645)
Mucosal inflammation (616)
Cytomegalovirus infection (446)
Product use in unapproved indication (425)
Pyrexia (359)
Drug ineffective (358)
Acute graft versus host disease in skin (355)
Acute graft versus host disease (331)
Cytomegalovirus infection reactivation (325)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which THIOTEPA Alternatives Have Lower Malignant neoplasm progression Risk?
THIOTEPA vs THIOTHIXENE
THIOTEPA vs THROMBIN
THIOTEPA vs THROMBIN HUMAN
THIOTEPA vs THYMOCYTE IMMUNE GLOBULIN NOS
THIOTEPA vs THYMOGLOBULINE